DEFLIP 6/30
Most reliable systemic glucorticosteroid
Deflip is used for its anti-inflammatory and immunosuppressant properties in Conditions responsive to corticosteroid therapy. Deflip works by acting within cells to prevent the release of certain chemicals that are important in the immune system. These chemicals are normally involved in producing immune and allergic responses, resulting in inflammation. By decreasing the release of these chemicals in a particular area, inflammation is reduced.
Indications:
• Anaphylaxis, asthma, severe hypersensitivity reactions.
• Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatic.
• Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease
• (other than systemic sclerosis),
• Polyarteritis nodosa, sarcoidosis.
• Pemphigus, bullous pemphigoid , pyoderma gangrenosum.
• Minimal change nephrotic syndrome, acute interstitial nephritis.
• Rheumatic carditis. .
• Ulcerative colitis, Crohn's disease.
• Uveitis, optic neuritis
• Autoimmune haemolytic anaemia, idiopathic thrombo-cytopenic purpura.
• Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma.
• Immune suppression in transplantation.
CORTLIP-50
Perfect approach to strengthen the senile body
Anabolic steroids are synthetic derivatives of testosterone. It Increases retention of Nitrogen, Calcium, and Sodium & Phosphate leads to an increase in skeletal weight & increased growth of bones. It improves blood picture in hypoplastic, haemolytic or maligancy associated anaemia.
INDICATIONS:
• Post Menopausal Osteoporosis
• Renal failure
• Anemia
• Low back pain
• Musculo Skeletal pain
• Post operative pain
• Arthritis
Mr.K Ragunathan, (48)
Chairman
The pharmaceutical industry needs a high level of consistency in terms of quality of drugs and medicines they manufacture and continue to strive for honouring commitments to clients. Globally there have been concerted efforts to monitor quality and regulate pharma operations for quality health care being extended to the target population.
Towards this end, we at Lipak India are constantly evolving to newer heights by placing our focus on Products, Processes and People as central themes to guide our business philosophy. With Innovation being a value driver, our strategic planning started in early 2011 with an ideation session analysing Lipak India's current strengths, weaknesses, opportunities and threats. We will be continuing our dialogue on strategic planning throughout the next several months, looking at financial health, research and development focus, management structure, operational efficiency, risk management, stakeholder communication, shareholder wealth creation and corporate social responsibility.
By the end of this process, we will be credited with a clear road map that will help us navigate smoothly through the challenges ahead.
Over the last decade many pharma organisations across India have started adopting various excellence initiatives. These initiatives are supposed to aid organisations in creating value and help face the challenging business needs. Let me hasten to add that Lipak India has seized this opportunity by adopting certain companywide initiatives such as management restructuring, venturing into newer business portfolios, enterprise resource planning, setting up HR governing council and adoption of operational excellence cell apart from culling out task force teams in quality and R&D with a view to provide the best pharma solutions to our esteemed clients
Lipak India stands today as one of the few distinguished vertically integrated pharmaceutical companies with a robust product portfolio produced out of our own approved manufacturing facilities, both in the areas of API and Formulations, with enviable longstanding business partnerships.
Over the years, we have grown from strength to strength and our global team of more than 9,500 scientists, technicians, sales, marketing, financial, manufacturing, quality, administrative and other business professional’s work together to achieve our global mission - "Committed to healthier life”.
We are sure that with the continued support and patronage of all our stakeholders, Lipak India will continue to enjoy the saga of business excellence in the healthcare sector in the coming periods, cutting across geographical boundaries.
We are Lipak India Ltd. “A global pharmaceutical company with great commitment to a healthier life".
